1. Home
  2. KNDI vs RCEL Comparison

KNDI vs RCEL Comparison

Compare KNDI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNDI
  • RCEL
  • Stock Information
  • Founded
  • KNDI 2002
  • RCEL 2020
  • Country
  • KNDI China
  • RCEL United States
  • Employees
  • KNDI N/A
  • RCEL N/A
  • Industry
  • KNDI Auto Manufacturing
  • RCEL Medical/Dental Instruments
  • Sector
  • KNDI Consumer Discretionary
  • RCEL Health Care
  • Exchange
  • KNDI Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • KNDI 154.6M
  • RCEL 274.7M
  • IPO Year
  • KNDI N/A
  • RCEL N/A
  • Fundamental
  • Price
  • KNDI $1.62
  • RCEL $10.47
  • Analyst Decision
  • KNDI
  • RCEL Hold
  • Analyst Count
  • KNDI 0
  • RCEL 3
  • Target Price
  • KNDI N/A
  • RCEL $15.00
  • AVG Volume (30 Days)
  • KNDI 247.7K
  • RCEL 89.6K
  • Earning Date
  • KNDI 11-06-2024
  • RCEL 11-07-2024
  • Dividend Yield
  • KNDI N/A
  • RCEL N/A
  • EPS Growth
  • KNDI N/A
  • RCEL N/A
  • EPS
  • KNDI N/A
  • RCEL N/A
  • Revenue
  • KNDI $124,609,232.00
  • RCEL $54,139,000.00
  • Revenue This Year
  • KNDI N/A
  • RCEL $40.31
  • Revenue Next Year
  • KNDI N/A
  • RCEL $45.42
  • P/E Ratio
  • KNDI N/A
  • RCEL N/A
  • Revenue Growth
  • KNDI N/A
  • RCEL 32.53
  • 52 Week Low
  • KNDI $1.52
  • RCEL $7.51
  • 52 Week High
  • KNDI $3.59
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • KNDI 43.38
  • RCEL 53.73
  • Support Level
  • KNDI $1.60
  • RCEL $9.74
  • Resistance Level
  • KNDI $1.79
  • RCEL $10.90
  • Average True Range (ATR)
  • KNDI 0.15
  • RCEL 0.46
  • MACD
  • KNDI -0.02
  • RCEL -0.05
  • Stochastic Oscillator
  • KNDI 4.26
  • RCEL 53.28

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: